Cheng Zhou
The Peking University People's Hospital · The Peking University People's Hospital, Beijing, Beijng · Peking University People's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Cheng Zhou as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:15 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07828639 · A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental VitiligoJiangsu vcare pharmaceutical technology co., LTD · not yet recruiting · Non-Segmental Vitiligo · principal investigator
- Ph1NCT07762443 · A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia AreataJiangsu vcare pharmaceutical technology co., LTD · recruiting · Alopecia Areata · principal investigator
- Ph2NCT07749716 · Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia AreataJiangsu vcare pharmaceutical technology co., LTD · recruiting · Alopecia Areata · principal investigator
- Ph3NCT07402213 · Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.Jemincare · recruiting · Chronic Spontaneous Urticaria · principal investigator
- Ph2NCT07076706 · Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic AlopeciaBeijing Dayspring Pharmaceutical Technology Co., Ltd · completed · Male Pattern of Hair Loss, Androgenic Alopecia, Androgenetic Alopecia (AGA) · study chair
- Ph3NCT06477835 · A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic DermatitisSimcere Pharmaceutical Co., Ltd · completed · Atopic Dermatitis · principal investigator
- Ph1NCT06175143 · A Study to Evaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis.Genrix (Shanghai) Biopharmaceutical Co., Ltd. · unknown · Atopic Dermatitis · principal investigator
- N/ANCT05685966 · Retrospective Study of COVID-19 on Reproductive FunctionJinling Hospital, China · unknown · COVID-19 · principal investigator
- N/ANCT05685992 · Novel Coronavirus Infection and Reproductive FunctionJinling Hospital, China · unknown · COVID-19 Infection · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 17 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:15 UTC. The ranking covers the 200 most relevant of 629 PubMed records, and a shared surname and initials can bring in a namesake. All 629 on PubMed
- Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.N Engl J Med · 20184,615 citationsRCR 168.8
- 3,498 citationsRCR 88.2
- Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.N Engl J Med · 20202,543 citationsRCR 114.6
- 1,319 citationsRCR 72.2
- 1,313 citationsRCR 39.5
- 862 citationsRCR 23.0
- 408 citationsRCR 19.3
- 406 citationsRCR 24.7
- 391 citationsRCR 10.4
- Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.N Engl J Med · 2023368 citationsRCR 29.4